MedPath

A Retrospective Study to Evaluate the Effectiveness of the Ulthera System

Completed
Conditions
Wrinkles
Skin Laxity
Registration Number
NCT01519934
Lead Sponsor
Ulthera, Inc
Brief Summary

Up to 120 subjects within the study site's practice who have already had an Ultherapy™ treatment to the face and neck will be enrolled to monitor treatment effectiveness. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained at each follow-up visit.

Detailed Description

This is a retrospective, single-center clinical trial to evaluate the efficacy of the Ulthera System for non-invasive treatment of skin texture and laxity six months after treatment. Global Aesthetic Improvement Scale scores, patient satisfaction questionnaires, and quality of life questionnaires will be obtained.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • Male or female, age 25-85 years.
  • Subject in good health.
  • Received Ultherapy™ treatment prior to or on October 1, 2011, and must have had pre-treatment baseline photographs taken.
  • Willingness and ability to comply with protocol requirements, including returning for follow-up visits.
  • Absence of physical or psychological conditions unacceptable to the investigator.
Exclusion Criteria
  • Presence of an active systemic or local skin disease that may affect wound healing.
  • Significant scarring in areas treated.
  • Open wounds or lesions in the areas treated.
  • Severe or cystic acne on the areas treated.
  • Inability to understand the protocol or to give informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in Overall Lifting and Tightening of the SkinBaseline to 180 days post-treatment

Determined by a masked, qualitative assessment of photographs at 180 days post treatment compared to pre-treatment baseline photographs. A panel of three blinded assessors reviewed pre-treatment and post-treatment photos. Each blinded assessor was provided an identical set of pre-treatment and Day 180 post-treatment photos to assess. The pre/post treatment photos were consistent in lighting, subject positioning and focus. The visit interval of each photo, i.e. pre and post treatment, was NOT marked. Each blinded assessor conducted their assessment independently with no input from another blinded assessor, comparing each set of photos. Each assessor indicated those subjects assessed as improved.

Secondary Outcome Measures
NameTimeMethod
Subject Perception of AgeBaseline to 180 days post-treatment

Percentage of subjects rated as "looking younger" as measured using a Subject Perception of Age questionnaire.

Patient Satisfaction180 days post-treatment

Percentage of subjects reporting satisfaction as measured using a Patient Satisfaction Questionnaire.

Overall Aesthetic ImprovementBaseline to 180 days post-treatment

Overall aesthetic improvement was assessed based on a Global Aesthetic Improvement Scale (GAIS) scores; PGAIS completed by a clinician assessor, SGAIS completed by the study subject. The GAIS is 5-point scale (1-5) describing an overall assessment as follows:

1. = Very Much Improved

2. = Much Improved

3. = Improved

4. = No Change

5. = Worse

Trial Locations

Locations (1)

Dermatology Cosmetic Laser Associates

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath